z-logo
open-access-imgOpen Access
Is non-prescription oseltamivir availability under strict criteria workable? A qualitative study in New Zealand
Author(s) -
Natalie Gauld,
Fiona Kelly,
John Shaw
Publication year - 2010
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkq409
Subject(s) - medical prescription , oseltamivir , pharmacist , public health , medicine , business , qualitative research , sample (material) , recall , family medicine , pharmacy , medical emergency , nursing , psychology , covid-19 , chemistry , disease , pathology , chromatography , infectious disease (medical specialty) , cognitive psychology , social science , sociology
in 2007, New Zealand became the first country to make oseltamivir (Tamiflu) available off prescription. Strict rules for supply were developed to ensure that potential public health benefits were balanced against possible risks. We wished to explore the success of implementing this unique decision through elucidating pharmacists' attitudes to and experiences of non-prescription supply of oseltamivir.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom